Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Authors
Keywords
-
Journal
MOLECULAR ASPECTS OF MEDICINE
Volume 93, Issue -, Pages 101205
Publisher
Elsevier BV
Online
2023-07-27
DOI
10.1016/j.mam.2023.101205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways
- (2023) Claudia Tito et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells
- (2022) Rachel E. Nicoletto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effects of doxorubicin on cardiac calcium homeostasis and contractile function
- (2022) Krekwit Shinlapawittayatorn et al. Journal of Cardiology
- Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins
- (2022) Qi Zeng et al. JOURNAL OF NATURAL PRODUCTS
- Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
- (2022) Mihad Ibrahim et al. Pharmaceutics
- Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells
- (2022) Natalia I. Moiseeva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative stress‐mediated up‐regulation of ABC transporters in lung cancer cells
- (2022) Tongkuo Yuan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
- (2022) Mahshid Deldar Abad Paskeh et al. LIFE SCIENCES
- Potential of Ferritin-Based Platforms for Tumor Immunotherapy
- (2022) Xiaoling Xu et al. MOLECULES
- Iron Promotes Cardiac Doxorubicin Retention and Toxicity Through Downregulation of the Mitochondrial Exporter ABCB8
- (2022) Archita Venugopal Menon et al. Frontiers in Pharmacology
- The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
- (2022) Zihan Si et al. Frontiers in Oncology
- Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review
- (2022) Sijongesonke Peter et al. MOLECULES
- PX478-loaded silk fibroin nanoparticles reverse multidrug resistance by inhibiting the hypoxia-inducible factor
- (2022) Zheng Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α
- (2022) Jiali Zhao et al. Drug Design Development and Therapy
- Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
- (2022) Wang Yin et al. Biomolecules
- A Comprehensive Review on Alginate-based Delivery Systems for the Delivery of Chemotherapeutic Agent: Doxorubicin
- (2021) Jaya R. Lakkakula et al. CARBOHYDRATE POLYMERS
- Targeting OCT3 attenuates doxorubicin-induced cardiac injury
- (2021) Kevin M. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
- (2021) Xianglan Yi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
- (2021) Amir Sadra Zangouei et al. Cancer Cell International
- Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
- (2021) Guo-Hua Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulated cell death pathways in doxorubicin-induced cardiotoxicity
- (2021) Effimia Christidi et al. Cell Death & Disease
- Overcoming Chemoresistance via Extracellular Vesicle Inhibition
- (2021) Raeesah Hayatudin et al. Frontiers in Molecular Biosciences
- The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
- (2021) Zahra Torki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Long non-coding RNAs in the doxorubicin resistance of cancer cells
- (2021) Saeed Ashrafizaveh et al. CANCER LETTERS
- Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
- (2021) Lingyue Gao et al. DRUG RESISTANCE UPDATES
- Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2
- (2021) Julia Kowal et al. JOURNAL OF MOLECULAR BIOLOGY
- Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
- (2021) Navneet Joshi et al. LIFE SCIENCES
- Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin
- (2021) Ponmathi Panneerpandian et al. TOXICOLOGY IN VITRO
- MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1
- (2021) Mengning Xia et al. World Journal of Surgical Oncology
- CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
- (2021) Hong Luo et al. Cell Death & Disease
- Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin
- (2021) Shirin Hekmatirad et al. Frontiers in Immunology
- CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
- (2021) Usama Khamis Hussein et al. Cells
- Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
- (2021) Sepideh Mirzaei et al. DRUG DISCOVERY TODAY
- The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
- (2021) Sepideh Mirzaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue
- (2021) Marcus Otter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years
- (2021) Natália A. D'Angelo et al. Materials Science & Engineering C-Materials for Biological Applications
- Anthracyclines: biosynthesis, engineering and clinical applications
- (2021) Mandy B. Hulst et al. NATURAL PRODUCT REPORTS
- Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review
- (2021) Francesco Mainini et al. Pharmaceutics
- SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway
- (2020) Shan Tian et al. Aging-US
- Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
- (2020) Eric C. Cheung et al. CANCER CELL
- Doxorubicin Inhibits Phosphatidylserine Decarboxylase and Modifies Mitochondrial Membrane Composition in HeLa Cells
- (2020) Nadège Bellance et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
- (2020) Jingqiu Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility
- (2020) Marion Delessard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells
- (2020) Francesca Rolle et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
- (2020) Xiaojing Cheng et al. Cell Death & Disease
- The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
- (2020) Zhaolin Chen et al. Molecular Therapy-Nucleic Acids
- LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
- (2020) Kewei Zhu et al. Aging-US
- Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin
- (2020) Jin Zhong et al. BIOCHEMICAL PHARMACOLOGY
- Antitumour Anthracyclines: Progress and Perspectives
- (2020) Maristela B. Martins‐Teixeira et al. ChemMedChem
- Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
- (2020) Emilia Licarete et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
- (2020) Shanshan Lei et al. Experimental and Therapeutic Medicine
- ABCG2 transports anticancer drugs via a closed-to-open switch
- (2020) Benjamin J. Orlando et al. Nature Communications
- Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
- (2020) Theo Battista et al. Cancers
- miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells
- (2020) Xiaoxin Shi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells
- (2020) Yonglong Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer
- (2020) Jing Yang et al. EXPERIMENTAL CELL RESEARCH
- Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
- (2020) Xiaohang Qiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural definition of polyspecific compensatory ligand recognition by P-glycoprotein
- (2020) Christina A. Le et al. IUCrJ
- Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
- (2020) Elizabeth Varghese et al. Cancers
- New insights into the activities and toxicities of the old anticancer drug doxorubicin
- (2020) Sabina Y. van der Zanden et al. FEBS Journal
- Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery
- (2020) Barbora Tesarova et al. JOURNAL OF CONTROLLED RELEASE
- Curcumin induces chemosensitization to doxorubicin in Duke’s type B coloadenocarcinoma cell line
- (2020) Jeyan Jayarajan et al. MOLECULAR BIOLOGY REPORTS
- Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1
- (2020) Sarah Hassan et al. PLoS One
- Aberrant DNA Methylation of ABC Transporters in Cancer
- (2020) Katja Zappe et al. Cells
- Studying Antitumor Effects of Sirna Gene Silencing of some Metabolic Genes in Pancreatic Ductal Adenocarcinoma
- (2020) Ahmad Sada Al hanjori et al. Current Molecular Pharmacology
- Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
- (2020) Yihan Yao et al. Frontiers in Molecular Biosciences
- Formaldehyde-doxorubicin dual polymeric drug delivery system for higher efficacy and limited cardiotoxicity of anthracyclines
- (2020) Estela Ordonez et al. EUROPEAN POLYMER JOURNAL
- Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR ‐542‐5p
- (2020) Wei‐Song Wang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
- (2020) Ievgenia Pastushenko et al. NATURE
- A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
- (2020) Rui-Ming Liu et al. PHYTOMEDICINE
- Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization
- (2020) Shravanti Mukherjee et al. Cell Death & Disease
- Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
- (2020) Gennaro Sanità et al. Frontiers in Molecular Biosciences
- miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer
- (2020) Hui Zhang et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
- (2019) Lanlan Gao et al. EBioMedicine
- Early Cardiac Mitochondrial Molecular and Functional Responses to Acute Anthracycline Treatment in Wistar Rats
- (2019) Gonçalo C Pereira et al. TOXICOLOGICAL SCIENCES
- Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
- (2019) Amer Alam et al. SCIENCE
- Ferroptosis as a target for protection against cardiomyopathy
- (2019) Xuexian Fang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- microRNA‐431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma
- (2019) Grace T.Y. Kwok et al. ONCOLOGIST
- The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells
- (2019) Kamila Środa-Pomianek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines
- (2019) Li Chen et al. AAPS PHARMSCITECH
- Dual-Ligand Modification of PEGylated Liposomes Used for Targeted Doxorubicin Delivery to Enhance Anticancer Efficacy
- (2019) Cong Li et al. AAPS PHARMSCITECH
- Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
- (2019) Jiarong Bao et al. BMC Medical Genomics
- Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
- (2019) Salih Demir et al. HAEMATOLOGICA
- Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
- (2019) Qiang Cai et al. Molecular Cancer
- Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer
- (2019) Kun Li et al. PHYTOTHERAPY RESEARCH
- Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway
- (2019) Hong Cai et al. PHYTOTHERAPY RESEARCH
- Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes
- (2019) Poliana Camila Marinello et al. Scientific Reports
- MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer
- (2019) Jinzhi Lai et al. BMC CANCER
- Chemotherapy-induced distal enhancers drive transcriptional program to maintain the chemoresistant state in ovarian cancer.
- (2019) Stephen Shang et al. CANCER RESEARCH
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin
- (2019) Javier Menéndez-Menéndez et al. Cancers
- Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy
- (2019) Rimpy Dhingra et al. CARDIOVASCULAR RESEARCH
- Doxorubicin and Lovastatin co-delivery liposomes for synergistic therapy of liver cancer
- (2019) Tianying Wang et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
- (2019) Shu Lin et al. Cell Death & Disease
- Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression
- (2019) Congren Wang et al. MOLECULAR GENETICS AND GENOMICS
- Cancer Cell Membrane Decorated Silica Nanoparticle Loaded with miR495 and Doxorubicin to Overcome Drug Resistance for Effective Lung Cancer Therapy
- (2019) Jinyuan He et al. Nanoscale Research Letters
- pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer
- (2019) Sipei Zhang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma
- (2019) Meijuan Geng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma
- (2019) Fengxia Mao et al. Cancer Cell International
- Doxorubicin‐induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways
- (2019) Ali A. Shati CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Towards the overcoming of anticancer drug resistance mediated by p53 mutations
- (2019) Xin Cao et al. DRUG RESISTANCE UPDATES
- Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells
- (2019) James H. Doroshow Oxidative Medicine and Cellular Longevity
- miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
- (2019) Feiya Du et al. Cell Death & Disease
- APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
- (2019) Casey D. Stefanski et al. NEOPLASIA
- Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
- (2018) Kelong Fan et al. ACS Nano
- Autophagy and doxorubicin resistance in cancer
- (2018) Chao Chen et al. ANTI-CANCER DRUGS
- Extracellular vesicles and anti-Cancer drug resistance
- (2018) Niamh Mc Namee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway
- (2018) Xiao-ming Wang et al. CANCER BIOLOGY & THERAPY
- miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
- (2018) Dawei Wu et al. CANCER GENE THERAPY
- Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs
- (2018) Elimelech Nesher et al. CANCER RESEARCH
- MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer
- (2018) Jin-Won Lee et al. CANCER SCIENCE
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Self-resistance mechanisms to DNA-damaging antitumor antibiotics in actinobacteria
- (2018) Elodie Tenconi et al. CURRENT OPINION IN MICROBIOLOGY
- Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells
- (2018) Logeswari Ponnusamy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling
- (2018) Peter Reichardt et al. Future Oncology
- Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin
- (2018) Ako Azimi et al. GENE
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
- (2018) Johannes M. Waldschmidt et al. HAEMATOLOGICA
- Complete genome sequence of Streptomyces peucetius ATCC 27952, the producer of anticancer anthracyclines and diverse secondary metabolites
- (2018) Dipesh Dhakal et al. JOURNAL OF BIOTECHNOLOGY
- The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity
- (2018) Elisabetta Falvo et al. JOURNAL OF CONTROLLED RELEASE
- Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
- (2018) Iwao Ojima et al. JOURNAL OF NATURAL PRODUCTS
- Chemotherapy medication errors
- (2018) Saul N Weingart et al. LANCET ONCOLOGY
- Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer
- (2018) Mithil Soni et al. MOLECULAR CANCER RESEARCH
- Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era
- (2018) Helga U. van der Heul et al. NATURAL PRODUCT REPORTS
- Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63
- (2018) Marcel Tuppi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin
- (2018) Souleymane Abdoul-Azize et al. ONCOGENE
- Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1
- (2018) Amer Alam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas
- (2018) Natalia Saenz-Ponce et al. Science Translational Medicine
- Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy
- (2018) Hugh Sparks et al. Nature Communications
- Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63
- (2018) Marcel Tuppi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
- (2018) Johannes M. Waldschmidt et al. HAEMATOLOGICA
- LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial-mesenchymal transition through the Notch1 signaling pathway
- (2018) Wenxue Liu et al. Cancer Medicine
- pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells
- (2018) Tilahun Ayane Debele et al. BIOMACROMOLECULES
- Pien Tze Huang (片仔癀) Overcomes Doxorubicin Resistance and Inhibits Epithelial-Mesenchymal Transition in MCF-7/ADR Cells
- (2018) Xi Chen et al. Chinese Journal of Integrative Medicine
- A degradable triple temperature-, pH-, and redox-responsive drug system for cancer chemotherapy
- (2018) Bing Yu et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
- (2018) Xin Xiao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils
- (2018) Andreas Noack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug
- (2018) Wei Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells
- (2018) Jalal Choupani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Enhancing chemosensitivity of breast cancer stem cells by down regulating SOX2 and ABCG2 using Wedelolactone-encapsulated nanoparticles
- (2018) Sreemanti Das et al. MOLECULAR CANCER THERAPEUTICS
- A chemical defence against phage infection
- (2018) Sarah Kronheim et al. NATURE
- Anticancer activity of 2′-hydroxyflavanone towards lung cancer
- (2018) Sanjay Awasthi et al. Oncotarget
- Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment
- (2018) Alina Sesarman et al. Drug Delivery and Translational Research
- The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo
- (2018) Yan Wen et al. Acta Pharmaceutica Sinica B
- Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent
- (2018) Jieru Liu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells
- (2017) Logeswari Ponnusamy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
- (2017) Hongyu Shen et al. GENE
- Polymeric nanoparticles: Promising platform for drug delivery
- (2017) Khalid M. El-Say et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
- (2017) András Füredi et al. JOURNAL OF CONTROLLED RELEASE
- Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin
- (2017) Li Qin et al. JOURNAL OF DRUG TARGETING
- Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
- (2017) Jiahui Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo
- (2017) Céline Bouvy et al. LEUKEMIA RESEARCH
- Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin
- (2017) Marta Denel-Bobrowska et al. LIFE SCIENCES
- Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin
- (2017) Xia Sheng et al. MOLECULAR CANCER RESEARCH
- MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma
- (2017) Ren Chen et al. Molecular Medicine Reports
- Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein
- (2017) Brandy Verhalen et al. NATURE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes
- (2017) Jochem Louisse et al. TOXICOLOGY IN VITRO
- Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation
- (2017) Zong-Lin Zhang et al. Breast Cancer
- Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells
- (2017) Ilaria Genovese et al. Cell Death & Disease
- MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
- (2017) Fangfang Jin et al. Cell Death & Disease
- Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
- (2017) Jian Yang et al. Oncology Letters
- siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells
- (2017) Linlin Li et al. Oncology Letters
- MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
- (2017) Yi Xiao et al. Oncology Letters
- MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway
- (2017) Yan Shu et al. Oncotarget
- Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
- (2017) Radosław Januchowski et al. Oncotarget
- Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy
- (2017) Zhengguang Wang et al. Oncotarget
- LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
- (2017) Zhu Kun-Peng et al. Oncotarget
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome
- (2017) Austin Yan et al. ACS Infectious Diseases
- Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress
- (2017) Amara Maryam et al. Scientific Reports
- The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes
- (2017) Stefano Palazzolo et al. CURRENT MEDICINAL CHEMISTRY
- Doxorubicin-induced epithelial–mesenchymal transition through SEMA 4A in hepatocellular carcinoma
- (2016) Jie-Xue Pan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
- (2016) J. J. Bartlett et al. BIOCHEMICAL JOURNAL
- New signal transduction paradigms in anthracycline-induced cardiotoxicity
- (2016) Alessandra Ghigo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells
- (2016) Hai Wang et al. BIOMATERIALS
- Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia
- (2016) S. Piya et al. BLOOD
- Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer
- (2016) Monica K. VanKlompenberg et al. BMC CANCER
- Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
- (2016) Baoqing Guo et al. BMC CANCER
- Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome AcidificationCLINICAL PERSPECTIVE
- (2016) Dan L. Li et al. CIRCULATION
- Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
- (2016) Yang Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
- (2016) Gene C. Jamieson et al. DRUGS
- MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway
- (2016) Hongyu Shen et al. GENE
- A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses
- (2016) Eric H. Bent et al. GENES & DEVELOPMENT
- ESHRE Guideline: management of women with premature ovarian insufficiency
- (2016) HUMAN REPRODUCTION
- A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma
- (2016) MASAFUMI YAMASHITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Multimodal transfer of MDR by exosomes in human osteosarcoma
- (2016) ELENA TORREGGIANI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors
- (2016) Golam Kibria et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity
- (2016) Lothar Esser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness
- (2016) Giulio Fracasso et al. JOURNAL OF CONTROLLED RELEASE
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde
- (2016) Benjamin L. Barthel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism
- (2016) Ann-Marie Meredith et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models
- (2016) Mohamad Hadla et al. Nanomedicine
- Decursin inAngelica gigasNakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression
- (2016) Hyeong Sim Choi et al. PHYTOTHERAPY RESEARCH
- Inhibition of human anthracycline reductases by emodin — A possible remedy for anthracycline resistance
- (2016) Jan Hintzpeter et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway
- (2016) Dan-dan Wang et al. TUMOR BIOLOGY
- The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration
- (2016) A E Hall et al. Cell Death & Disease
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
- (2016) Lifen Zhao et al. Oncotarget
- MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway
- (2016) Zhiyun Zheng et al. Oncotarget
- Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3
- (2016) Bing Tu et al. Oncotarget
- A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer
- (2016) Do Yeon Kim et al. Oncotarget
- Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients
- (2016) Nobuyuki Horita et al. Scientific Reports
- Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2
- (2016) Yuan Rong et al. Scientific Reports
- MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program
- (2016) Jing Xu et al. Cell Discovery
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts
- (2015) Tae Hyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- MAPK/JNK signaling: A potential autophagy regulation pathway
- (2015) Yuan-Yuan Zhou et al. BIOSCIENCE REPORTS
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
- (2015) Man Yu et al. CANCER SCIENCE
- Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression
- (2015) Z Li et al. CELL DEATH AND DIFFERENTIATION
- Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo–keto reductase 1B10
- (2015) Yoshifumi Morikawa et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone
- (2015) R. Koch et al. CLINICAL CANCER RESEARCH
- Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance
- (2015) Ariane Roseblade et al. CURRENT CANCER DRUG TARGETS
- Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
- (2015) Derek Edwardson et al. CURRENT DRUG METABOLISM
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery
- (2015) Huan Xu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells
- (2015) Ji Na Kong et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
- (2015) Leila Arabi et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia
- (2015) Limin Liu et al. LEUKEMIA RESEARCH
- RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma
- (2015) M. Hazar-Rethinam et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues
- (2015) LI WANG et al. Molecular Medicine Reports
- Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin
- (2015) Giuseppe Toffoli et al. Nanomedicine
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Chemical profiling of the genome with anti-cancer drugs defines target specificities
- (2015) Baoxu Pang et al. Nature Chemical Biology
- MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy
- (2015) RUIDA XU et al. ONCOLOGY REPORTS
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology
- (2015) Paolo Bernardi et al. PHYSIOLOGICAL REVIEWS
- Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines
- (2015) Shi Qinghong et al. Proteome Science
- pH Gradient Reversal: An Emerging Hallmark of Cancers
- (2015) Mohit Sharma et al. Recent Patents on Anti-Cancer Drug Discovery
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma
- (2015) A J Novak et al. Blood Cancer Journal
- Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
- (2015) Yue Zhou et al. Oncotarget
- Structural basis of Sorcin-mediated calcium-dependent signal transduction
- (2015) Andrea Ilari et al. Scientific Reports
- Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
- (2015) Hyeon-Jun Shin et al. Scientific Reports
- Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs
- (2015) Caecilia HC Sukowati et al. Expert Review of Gastroenterology & Hepatology
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein
- (2015) Paul Szewczyk et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults
- (2015) Richard A Anderson et al. Lancet Diabetes & Endocrinology
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice
- (2015) Jenna Kropp et al. PLoS One
- miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
- (2015) Zuoren Yu et al. Oncotarget
- 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin
- (2015) Dong-Gun Kim et al. Oncotarget
- Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance
- (2015) Eran E. Bram et al. NEOPLASIA
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Reversing Effect of Sorcin in the Drug Resistance of Human Nasopharyngeal Carcinoma
- (2014) Xuebing Liu et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- An Epigenetic Mechanism Underlying Doxorubicin Induced EMT in the Human BGC-823 Gastric Cancer Cell
- (2014) Rong-Fei Han et al. Asian Pacific Journal of Cancer Prevention
- Triggered Release of Doxorubicin from Temperature-Sensitive Poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) Grafted Liposomes
- (2014) Merel van Elk et al. BIOMACROMOLECULES
- Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line
- (2014) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells
- (2014) Hyun Ji Kim et al. Biomolecules & Therapeutics
- A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
- (2014) Yifan Tu et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation
- (2014) Zhen Zhao et al. CANCER BIOLOGY & THERAPY
- Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance
- (2014) Zhongwei Cao et al. CANCER CELL
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- A Novel E2F/Sphingosine Kinase 1 Axis Regulates Anthracycline Response in Squamous Cell Carcinoma
- (2014) M. Hazar-Rethinam et al. CLINICAL CANCER RESEARCH
- Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance
- (2014) Fang-fang Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Doxorubicin alters the mitochondrial dynamics machinery and mitophagy in the liver of treated animals
- (2014) Amie J. Dirks-Naylor et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Gene expression alterations in chronic hypoxic MCF7 breast cancer cell line
- (2014) Feda' H. Hamdan et al. GENOMICS
- In vivodisposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters
- (2014) Selvi Durmus et al. INTERNATIONAL JOURNAL OF CANCER
- The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors
- (2014) GABRIELA NESTAL DE MORAES et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Localized delivery of doxorubicin in vivo from polymer-modified thermosensitive liposomes with MR-guided focused ultrasound-mediated heating
- (2014) Terence Ta et al. JOURNAL OF CONTROLLED RELEASE
- Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes
- (2014) Bilyana M. Dicheva et al. JOURNAL OF CONTROLLED RELEASE
- Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes
- (2014) S. A. Rushworth et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
- (2014) Na Zhao et al. Molecular Cancer
- Targeted polytherapy in small cell sarcoma and its association with doxorubicin
- (2014) S.N. Dumont et al. Molecular Oncology
- Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
- (2014) Yarong Liu et al. MOLECULAR PHARMACEUTICS
- Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals
- (2014) Taili Zong et al. MOLECULAR PHARMACEUTICS
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Bacterial solutions to multicellularity: a tale of biofilms, filaments and fruiting bodies
- (2014) Dennis Claessen et al. NATURE REVIEWS MICROBIOLOGY
- Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p
- (2014) YANMING PAN et al. ONCOLOGY REPORTS
- Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
- (2014) Mike-Andrew Westhoff et al. PLoS One
- Sorcin Links Calcium Signaling to Vesicle Trafficking, Regulates Polo-Like Kinase 1 and Is Necessary for Mitosis
- (2014) Vasiliki S. Lalioti et al. PLoS One
- Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs
- (2014) Wei-xian Chen et al. PLoS One
- Bortezomib Prevents Acute Doxorubicin Ovarian Insult and Follicle Demise, Improving the Fertility Window and Pup Birth Weight in Mice
- (2014) Elon C. Roti Roti et al. PLoS One
- Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance
- (2014) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
- (2014) M. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
- (2014) D Ciavardelli et al. Cell Death & Disease
- Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer
- (2014) Kenji Takahashi et al. FEBS Open Bio
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
- (2013) Su Chul Jang et al. ACS Nano
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Doxorubicin-antioxidant co-drugs
- (2013) Konstantin Chegaev et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
- (2013) Krupa J. Patel et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer
- (2013) Swati Biswas et al. CANCER LETTERS
- CDK4 inhibition restores G₁-S arrest inMYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
- (2013) Sina Gogolin et al. CELL CYCLE
- An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
- (2013) Steven M. Jay et al. CIRCULATION
- Doxorubicin Enhances Nucleosome Turnover around Promoters
- (2013) Fan Yang et al. CURRENT BIOLOGY
- MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
- (2013) Tao Yang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin
- (2013) Qi Shen et al. FEBS LETTERS
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling
- (2013) Erik Wennerberg et al. INTERNATIONAL JOURNAL OF CANCER
- Maspin influences response to doxorubicin by changing the tumor microenvironment organization
- (2013) Tiziana Triulzi et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer
- (2013) BERLINDA VERDOODT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Magnetic Resonance Guided High-Intensity Focused Ultrasound Mediated Hyperthermia Improves the Intratumoral Distribution of Temperature-Sensitive Liposomal Doxorubicin
- (2013) Mariska de Smet et al. INVESTIGATIVE RADIOLOGY
- Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin
- (2013) Wenkai Ni et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy
- (2013) Hamidreza Montazeri Aliabadi et al. JOURNAL OF CONTROLLED RELEASE
- Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy
- (2013) Li Li et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
- (2013) Leibo Xu et al. JOURNAL OF HEPATOLOGY
- F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity
- (2013) A Kruczynski et al. LEUKEMIA
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells
- (2013) Martin Werner et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells
- (2013) A A Takwi et al. ONCOGENE
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
- (2013) Anna Vavrova et al. PLoS One
- Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
- (2013) De-Kuan Chang et al. PLoS One
- Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
- (2013) Yan Xu et al. PLoS One
- Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
- (2013) A. B. Ward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human ferritin for tumor detection and therapy
- (2013) Kelong Fan et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling
- (2012) Sonja M. Kessler et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways
- (2012) R.A. Bilardi et al. BIOCHEMICAL PHARMACOLOGY
- Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
- (2012) Robert A. Forrest et al. BIOCHEMICAL PHARMACOLOGY
- Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
- (2012) Balindiwe J.N. Sishi et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia
- (2012) Wafa' T. Al-Jamal et al. BIOMATERIALS
- The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer
- (2012) Zhaohui Wang et al. BIOMATERIALS
- Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
- (2012) Zhen Zeng et al. BMC CANCER
- Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
- (2012) Allan D Heibein et al. BMC CANCER
- Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma
- (2012) Youhei Tanaka et al. CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin
- (2012) Mostafa Shahin et al. CANCER LETTERS
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Bacterial Inactivation of the Anticancer Drug Doxorubicin
- (2012) Erin L. Westman et al. CHEMISTRY & BIOLOGY
- The UCSF-FDA TransPortal: A Public Drug Transporter Database
- (2012) K M Morrissey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
- (2012) S.-M. He et al. CURRENT MEDICINAL CHEMISTRY
- Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
- (2012) A. Palmeira et al. CURRENT MEDICINAL CHEMISTRY
- Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
- (2012) Ngoc Bich Vu et al. CYTOTECHNOLOGY
- Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
- (2012) Zhongya Chen et al. International Journal of Nanomedicine
- Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice
- (2012) François-Xavier Dieudonné et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3
- (2012) J. Hagenbuchner et al. JOURNAL OF CELL SCIENCE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2
- (2012) Francesca Fornari et al. JOURNAL OF PATHOLOGY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
- (2012) Kamlesh Shroff et al. LANGMUIR
- Topological domains in mammalian genomes identified by analysis of chromatin interactions
- (2012) Jesse R. Dixon et al. NATURE
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression
- (2012) Xiuxiu Lv et al. PLoS One
- Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart
- (2012) K. Krishnamurthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
- (2012) Joseph G. Reynolds et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma
- (2012) Cheng-lin Yang et al. TUMOR BIOLOGY
- Activation of β-catenin signaling is critical for doxorubicin-induced epithelial–mesenchymal transition in BGC-823 gastric cancer cell line
- (2012) Rongfei Han et al. TUMOR BIOLOGY
- Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents
- (2012) Ian G. Cowell et al. International Journal of Environmental Research and Public Health
- Remote Triggered Release of Doxorubicin in Tumors by Synergistic Application of Thermosensitive Liposomes and Gold Nanorods
- (2011) Abhiruchi Agarwal et al. ACS Nano
- SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
- (2011) Hsieh-Cheng Chen et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
- (2011) Hege O Ohnstad et al. BMC CANCER
- The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB
- (2011) H Jacobs et al. BRITISH JOURNAL OF CANCER
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21
- (2011) N. Tsuchiya et al. CANCER RESEARCH
- Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth
- (2011) J. Chen et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
- (2011) Giovanni Ligresti et al. CELL CYCLE
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- Substrate and product specificities of SET domain methyltransferases
- (2011) Paul A. Del Rizzo et al. Epigenetics
- Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats
- (2011) A.H.M Viswanatha Swamy et al. INDIAN JOURNAL OF PHARMACOLOGY
- RNA Interference Targeting Slug Increases Cholangiocarcinoma Cell Sensitivity to Cisplatin via Upregulating PUMA
- (2011) Kejun Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
- (2011) Ka-Kei Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin
- (2011) Tatsuaki Tagami et al. JOURNAL OF CONTROLLED RELEASE
- Involvement of the NF-κB pathway in multidrug resistance induced by HBx in a hepatoma cell line
- (2011) Y. Liu et al. JOURNAL OF VIRAL HEPATITIS
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
- (2011) Wei Wei et al. Molecular Cancer
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA Damage Signaling Pathway
- (2010) X. Zhang et al. CANCER RESEARCH
- MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2010) Francesca Fornari et al. CANCER RESEARCH
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway
- (2010) Xiao Qi Wang et al. HEPATOLOGY
- Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
- (2010) Kun Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
- (2010) Tongsen Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell
- (2010) Min-Bin Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
- (2010) Michael F. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors
- (2010) Amanda Lowery et al. JOURNAL OF CONTROLLED RELEASE
- Activation of the cardiac Na+–Ca2+ exchanger by sorcin via the interaction of the respective Ca2+-binding domains
- (2010) Carlotta Zamparelli et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium
- (2010) David Montaigne et al. MITOCHONDRION
- Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
- (2010) Alena Vaculova et al. Molecular Cancer
- Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer
- (2010) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Magnetic tweezers measurements of the nanomechanical properties of DNA in the presence of drugs
- (2010) D. Salerno et al. NUCLEIC ACIDS RESEARCH
- Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer
- (2010) Jie Chen et al. PLoS One
- Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
- (2010) Constanze Zeller et al. Therapeutic Advances in Medical Oncology
- PARP-1 is involved in autophagy induced by DNA damage
- (2009) José Antonio Muñoz-Gámez et al. Autophagy
- NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis
- (2009) Mylène Gilleron et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line
- (2009) Roberto Mazzanti et al. BIOCHEMICAL PHARMACOLOGY
- Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin
- (2009) Xu Di et al. BIOCHEMICAL PHARMACOLOGY
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Nucleosome Assembly Depends on the Torsion in the DNA Molecule: A Magnetic Tweezers Study
- (2009) Pooja Gupta et al. BIOPHYSICAL JOURNAL
- Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia
- (2009) A. N. Mays et al. BLOOD
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
- (2009) M. Pajic et al. CANCER RESEARCH
- MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2009) F. Fornari et al. CANCER RESEARCH
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
- (2009) R. Graeser et al. INVESTIGATIONAL NEW DRUGS
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
- (2009) M Bebawy et al. LEUKEMIA
- Repression of BIRC5/Survivin by FOXO3/FKHRL1 Sensitizes Human Neuroblastoma Cells to DNA Damage-induced Apoptosis
- (2009) Petra Obexer et al. MOLECULAR BIOLOGY OF THE CELL
- iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
- (2009) Sara De Boo et al. Molecular Cancer
- ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome
- (2009) Aaron M. Elliott et al. MOLECULAR CANCER RESEARCH
- Sensors and regulators of intracellular pH
- (2009) Joseph R. Casey et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- When apoptosis meets autophagy: deciding cell fate after trauma and sepsis
- (2009) Ya-Ching Hsieh et al. TRENDS IN MOLECULAR MEDICINE
- Cancer stem cell epigenetics and chemoresistance
- (2009) Francesco Crea et al. Epigenomics
- Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
- (2008) Abdelhadi Rebbaa et al. ANGIOGENESIS
- Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
- (2008) Neil Ashley et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- A role for ceramide in driving cancer cell resistance to doxorubicin
- (2008) Yong-Yu Liu et al. FASEB JOURNAL
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration
- (2008) B Chapuy et al. LEUKEMIA
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
- (2008) J A McCubrey et al. LEUKEMIA
- The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
- (2008) R. C.-Y. Hui et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
- Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
- (2008) M. Okabe et al. MOLECULAR CANCER THERAPEUTICS
- Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
- (2008) R. C-Y. Hui et al. MOLECULAR CANCER THERAPEUTICS
- Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
- (2008) Maha Saad et al. Nanomedicine
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
- (2008) K. E. Coldwell et al. NUCLEIC ACIDS RESEARCH
- Dexrazoxane (TotectTM): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy
- (2008) R. C. Kane et al. ONCOLOGIST
- Topoisomerase levels determine chemotherapy responsein vitroandin vivo
- (2008) Darren J. Burgess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P-glycoprotein: So Many Ways to Turn It On
- (2007) Richard Callaghan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair
- (2007) Damian M.S. Spencer et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation